These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24789921)

  • 1. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.
    Laitakari A; Tapio J; Mäkelä KA; Herzig KH; Dengler F; Gylling H; Walkinshaw G; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    J Mol Med (Berl); 2020 May; 98(5):719-731. PubMed ID: 32296880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease.
    Laitakari A; Ollonen T; Kietzmann T; Walkinshaw G; Mennerich D; Izzi V; Haapasaari KM; Myllyharju J; Serpi R; Dimova EY; Koivunen P
    Redox Biol; 2019 Apr; 22():101145. PubMed ID: 30802717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel roles of hypoxia response system in glucose metabolism and obesity.
    Ichiki T; Sunagawa K
    Trends Cardiovasc Med; 2014 Jul; 24(5):197-201. PubMed ID: 24774124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl hydroxylase domain protein 2 plays a critical role in diet-induced obesity and glucose intolerance.
    Matsuura H; Ichiki T; Inoue E; Nomura M; Miyazaki R; Hashimoto T; Ikeda J; Takayanagi R; Fong GH; Sunagawa K
    Circulation; 2013 May; 127(21):2078-87. PubMed ID: 23630130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.
    Karsikas S; Myllymäki M; Heikkilä M; Sormunen R; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    J Mol Med (Berl); 2016 Mar; 94(3):301-10. PubMed ID: 26452676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the hypoxia response pathway protects against age-induced cardiac hypertrophy.
    Röning T; Magga J; Laitakari A; Halmetoja R; Tapio J; Dimova EY; Szabo Z; Rahtu-Korpela L; Kemppi A; Walkinshaw G; Myllyharju J; Kerkelä R; Koivunen P; Serpi R
    J Mol Cell Cardiol; 2022 Mar; 164():148-155. PubMed ID: 34919895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.
    Taniguchi CM; Finger EC; Krieg AJ; Wu C; Diep AN; LaGory EL; Wei K; McGinnis LM; Yuan J; Kuo CJ; Giaccia AJ
    Nat Med; 2013 Oct; 19(10):1325-30. PubMed ID: 24037093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Mäkinen S; Sree S; Ala-Nisula T; Kultalahti H; Koivunen P; Koistinen HA
    Diabetologia; 2024 Sep; 67(9):1943-1954. PubMed ID: 38814443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.
    Hyvärinen J; Hassinen IE; Sormunen R; Mäki JM; Kivirikko KI; Koivunen P; Myllyharju J
    J Biol Chem; 2010 Apr; 285(18):13646-57. PubMed ID: 20185832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.
    Wolf D; Jehle F; Michel NA; Bukosza EN; Rivera J; Chen YC; Hoppe N; Dufner B; Rodriguez AO; Colberg C; Nieto L; Rupprecht B; Wiedemann A; Schulte L; Peikert A; Bassler N; Lozhkin A; Hergeth SP; Stachon P; Hilgendorf I; Willecke F; von Zur Mühlen C; von Elverfeldt D; Binder CJ; Aichele P; Varo N; Febbraio MA; Libby P; Bode C; Peter K; Zirlik A
    Circulation; 2014 Jun; 129(23):2414-25. PubMed ID: 24664276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
    Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
    Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span.
    Laitakari A; Huttunen R; Kuvaja P; Hannuksela P; Szabo Z; Heikkilä M; Kerkelä R; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    FASEB J; 2020 Apr; 34(4):5590-5609. PubMed ID: 32100354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity.
    Choe SS; Shin KC; Ka S; Lee YK; Chun JS; Kim JB
    Diabetes; 2014 Oct; 63(10):3359-71. PubMed ID: 24947359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M.
    Poblete JMS; Ballinger MN; Bao S; Alghothani M; Nevado JB; Eubank TD; Christman JW; Magalang UJ
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E689-E700. PubMed ID: 32154744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.